Capitolis Liquid Global Markets’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.8M Buy
+664,600
New +$44.3M 0.19% 92
2026
Q1
Sell
-208,000
Closed -$13.8M 350
2025
Q4
$13.8M Buy
208,000
+33,000
+19% +$2.13M 0.08% 132
2025
Q3
$11.8M Hold
175,000
0.09% 127
2025
Q2
$15.3M Hold
175,000
0.11% 122
2025
Q1
$12M Hold
175,000
0.11% 110
2024
Q4
$13.6M Buy
+175,000
New +$13M 0.13% 74

Other funds holding DXCM

Capitolis Liquid Global Markets's DXCM Position: Q2 2026 in Review

Capitolis Liquid Global Markets opened a new position in DexCom (DXCM) in Q2 2026: 664,600 shares worth $44.8M. The stake represents 0.19% of the portfolio and ranks #92 among its holdings. This is a return to the name: Capitolis Liquid Global Markets previously reported a position in DXCM as recently as Q4 2025.

Capitolis Liquid Global Markets first reported a position in DXCM in Q4 2024 and has held it in 6 quarters since. 972 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Capitolis Liquid Global Markets held 664,600 shares of DexCom worth $44.8M as of Q2 2026.
  • DexCom was a new Capitolis Liquid Global Markets position in Q2 2026.
  • DexCom made up 0.19% of Capitolis Liquid Global Markets's portfolio in Q2 2026, its #92 holding.
  • Capitolis Liquid Global Markets first reported a position in DexCom in Q4 2024 and has held it in 6 quarters since.
  • 972 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.